Tseng, C. (2023). Tofacitinib treatment in anti‐glycyl‐tRNA synthetase antibody interstitial lung disease – A case report. International journal of rheumatic diseases, 26(4), 781-785. https://doi.org/10.1111/1756-185X.14516
Chicago Style (17th ed.) CitationTseng, Chih‐Wei. "Tofacitinib Treatment in Anti‐glycyl‐tRNA Synthetase Antibody Interstitial Lung Disease – A Case Report." International Journal of Rheumatic Diseases 26, no. 4 (2023): 781-785. https://doi.org/10.1111/1756-185X.14516.
MLA (9th ed.) CitationTseng, Chih‐Wei. "Tofacitinib Treatment in Anti‐glycyl‐tRNA Synthetase Antibody Interstitial Lung Disease – A Case Report." International Journal of Rheumatic Diseases, vol. 26, no. 4, 2023, pp. 781-785, https://doi.org/10.1111/1756-185X.14516.
Warning: These citations may not always be 100% accurate.